ONCOLife Articles
ARANOTE Trial: Darolutamide Shows Significant Quality-of-Life Improvements in mCS Prostate Cancer
ONCOLife | 4 June 2025
ATOMIC Trial: Atezolizumab Combo Halves Recurrence in Stage III dMMR Colon Cancer
ONCOLife | 3 June 2025
Targeted ADC ZL-1310 Shows Promising 67% ORR in Heavily Pretreated ES-SC Lung Cancer
ONCOLife | 5 June 2025
Darzalex Faspro Achieves Outstanding Results in Multiple Myeloma with 95% 4-Year PFS
ONCOLife | 5 June 2025
Vividion and Bayer Advance First-in-Class WRN Inhibitor VVD-214 for Solid Tumors
Pharma | 4 June 2025
Imdelltra Extends Survival in Small Cell Lung Cancer, Cutting Death Risk by 40%
ONCOLife
2 June 2025
The Latest Issue of ONCOLife Is Now Live – Follow the Cutting Edge of Oncology Innovation
ONCOLife
15 May 2025
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
ONCOLife
27 May 2025
START and OneOncology Partnership Expands Clinical Trials from Academia to Community
Clinical Trials
27 May 2025
DNA-Based Immunotherapy IMNN-001 Shows Survival Gains in Advanced Ovarian Cancer
Clinical Trials
23 May 2025
How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials
ONCOLife
22 May 2025
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
Clinical Trials
15 May 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
